Skip to Content
Merck
CN
  • Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies.

Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies.

Proceedings of the National Academy of Sciences of the United States of America (1984-11-01)
A H Ross, P Grob, M Bothwell, D E Elder, C S Ernst, N Marano, B F Ghrist, C C Slemp, M Herlyn, B Atkinson
ABSTRACT

The nerve growth factor (NGF) receptor was characterized by using a new series of anti-receptor monoclonal antibodies (MAbs). These MAbs (i) showed significantly greater reactivity with a melanoma cell line expressing higher levels of NGF receptor, (ii) inhibited the binding of 125I-labeled NGF to its receptor, and (iii) immunoprecipitated both metabolically labeled and 125I-labeled NGF affinity-labeled receptor. These experiments defined the receptor as a 75-kDa cell-surface protein. The NGF receptor was visualized by immunoperoxidase staining in tissue sections of human nevi, melanomas, neurofibromas, a pheochromocytoma, and peripheral nerves. Uniform staining of the cytoplasm suggests that, in addition to cell-surface NGF receptors, there is a population of intracellular receptors.